Drug-induced revertants of adenovirus-transformed cells: retransformation by 5-azacytidine without reactivation of E1a

References

1. Babiss L. E., Zimmer S. G., Fisher P. B. 1985; Reversibility of progression of the transformed phenotype in Ad5-transformed rat embryo cells. Science 228:1099–1101
   [Google Scholar]
2. Benedict W. F., Banerjee A., Gardner A., Jones P. A. 1977; Induction of morphological transformation in mouse C3H/10T 1/2 clone cells and chromosomal damage in hamster A (T) C13 cells by cancer chemotherapeutic agents. Cancer Research 37:2202–2208
   [Google Scholar]
3. Bird A. P. 1986; DNA methylation-how important in gene control?. Nature; London: 307503–504
   [Google Scholar]
4. Carr B. I., Reilly J. G., Smith S. S., Winberg C., Riggs A. 1984; The tumorigenicity of 5-azacytidine in the male Fischer rat. Carcinogenesis 5:1583–1590
   [Google Scholar]
5. Cheah M. S. C., Wallace C. D., Hoffman R. 1984; Hypomethylation of DNA in human cancer cells: a site specific change in the c-myconcogenes. Journal of the National Cancer Institute 73:1057–1061
   [Google Scholar]
6. Delers A., Szpirer J., Saggioro D. 1984; Spontaneous and 5- azacytidine-induced reexpression of ornithine carbamoyl transferase in hepatoma cells. Molecular and Cellular Biology 4:709–812
   [Google Scholar]
7. Feinberg A. P., Vogelstein B. 1983; Hypomethylation of rasoncogenes in primary human cancers. Biochemical and Biophysical Research Communications 198:47–54
   [Google Scholar]
8. Flint S. J. 1981; Transformation by adenoviruses. In DNA Tumor Viruses pp 547–576 Tooze J. Edited by New York: Cold Spring Harbor Laboratory;
   [Google Scholar]
9. Frost P., Liteplo R. G., Donaghue R. P., Kerbel R. S. 1984; The selection of strongly immunogenic tumor variants from tumors at high frequency using 5-azacytidine. Journal of Experimental Medicine 159:1491–1501
   [Google Scholar]
10. Gallimore P. H., McDougall J. K., Chen L. B. 1977; In vitrotraits of adenovirus-transformed cell lines and their relevance to tumorogenicity in nude mice. Cell 10:669–678
    [Google Scholar]
11. Gama-Sosa M. A., Siagel V. A., Trewyn R. W., Oxenharndler R., Kuo K. C., Gehrke C. W., Ehrlich M. 1983; The 5- methylcytosine content of DNA from human tumors. Nucleic Acids Research 11:6883–6894
    [Google Scholar]
12. Harrison J. J., Anisowicz A., Giardi I. K., Raffeld M., Sagar R. 1983; Azacytidine induced tumorigenesis of CHEF/18 cells: correlated DNA methylation and chromosome changes. Proceedings of the National Academy of Sciences U.S.A.: 806606–6610
    [Google Scholar]
13. Hsiao W. L. W., Gattoni-Celli S., Weinstein I. B. 1985; Effect of 5-azacytidine on the progressive nature of cell transformation. Molecular and Cellular Biology 5:1800–1803
    [Google Scholar]
14. Jones P. A. 1985; Altering gene expression with 5-azacytidine. Cell 40:485–486
    [Google Scholar]
15. Jones P. A. 1986; DNA methylation and cancer. Cancer Research 46:461–466
    [Google Scholar]
16. Kerbel R. S., Frost P., Liteplo R., Carlow D., Elliott B. E. 1984; Possible epigenetic mechanism of tumor progression: induction of high frequency heritable but phenotypically unstable changes in the tumorigenic and metastatic properties of tumor cell populations by 5-azacytidine treatment. Journal of Cellular Physiology supplement 3:87–97
    [Google Scholar]
17. Kuhlmann I., Doerfler W. 1983; Loss of viral genomes from hamster tumor cells and nonrandom alterations in patterns of methylation of integrated adenovirus type 12 DNA. Journal of Virology 47:631–636
    [Google Scholar]
18. Landolph J. R., Jones P. A. 1982; Mutagenicity of 5-azacytidine and related nucleosides in C3H/10T 1/2 C18 and V79 cells. Cancer Research 42:817–823
    [Google Scholar]
19. Lapeyre J. N., Walker M. S., Becker F. F. 1981; DNA methylation and methylase levels in normal and malignant mouse hepatic tissues. Carcinogenesis 4:587–598
    [Google Scholar]
20. Maniatis T. E., Fritsch F., Sambrook J. 1982 Molecular Cloning’. A Laboratory Manual New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
21. Nyce J., Weinhouse S., Magee P. N. 1983; 5-methylcytosine depletion during tumor development: an extension of the miscoding concept. British Journal of Cancer 48:463–475
    [Google Scholar]
22. Olsson L., Forchhammer J. 1984; Induction of the metastatic phenotype in a mouse tumor model by 5-azacytidine, and characterization of an antigen associated with metastatic activity. Proceedings of the National Academy of Sciences U.S.A.: 813389–3393
    [Google Scholar]
23. Olsson L, Due C., Diamont M. 1985; Treatment of human cell lines with 5-azacytidine may result in profound alterations in clonogenicity and growth rate. Journal of Cellular Biology 100, 508513
    [Google Scholar]
24. Riggs A. D., Jones P. A. 1983; 5-methylcytosine, gene regulation and cancer. Advances in Cancer Research 40:1–30
    [Google Scholar]
25. Rodrigues M. T., Palkonyay L., Sircar S., Fleurent J., Dessureault J., Weber J. M. 1987; Isolation and uptake characteristics of adenovirus transformed cell revertants resistant to the antiproliferative effects of methylglyoxal bis(guanylhydrazone). Biochemical and Biophysical Research Communications 147:675–681
    [Google Scholar]
26. Samid D., Flessate D. M., Friedman R. M. 1987; Interferon- induced revertants of rat-transformed cells: resistance to transformation by specific oncogenes and retransformation by 5-azacytidine. Molecular and Cellular Biology 7:2196–2200
    [Google Scholar]
27. Seif R., Cuzin F. 1977; Temperature-sensitive growth regulation in one type of transformed rat cells induced by the tsamutant of polyoma virus. Journal of Virology 24:721–728
    [Google Scholar]
28. Sircar S., Weber J. M. 1988; Normalization of epidermal growth factor receptor and transforming growth factor production in drug resistant variants derived from adenovirus transformed cells. Journal of Cellular Physiology 134:467–472
    [Google Scholar]
29. Sircar S., Palkonyay L, Allaire S., Horvath J., Thirion J.-P., Weber J. 1987; Isolation of variants resistant to methylglyoxal bis(guanylhydrazone) from adenovirus-transformed rat cells. Cancer Research 47:1339–1343
    [Google Scholar]
30. Sircar S., Rodrigues M., Weber J. M. 1988; Resistance to retransformation by adenovirus but not by heterologous oncogenes in an El-positive transformation revertant cell line may be mediated by a cellular function. Oncogene 3:725–728
    [Google Scholar]
31. Wigler M., Levy D., Perucho M. 1981; The somatic replication of DNA methylation. Cel! 24:33–40
    [Google Scholar]